Advances in Cardiomyopathies: Proceedings of the II Florence Meeting on Advances on Cardiomyopathies April 24–26, 1997

Front Matter....Pages I-XV
Introduction: II Florence Meeting on Advances in Cardiomyopathies....Pages 1-2
The Classification of Cardiomyopathies....Pages 3-13
Front Matter....Pages 15-15
The Clinical Significance of Genetic Testing in Familial Hypertrophic Cardiomyopathy....Pages 17-21
The Italian Multicentric Study on Hypertrophic Cardiomyopathy: I. Natural History and Clinical Course of Unselected Patients....Pages 22-27
The Italian Multicentric Study on Hypertrophic Cardiomyopathy: II. Prognostic Assessment in Symptomatic Patients....Pages 28-35
Detection and Clinical Consequences of Myocardial Ischemia and Reduced Coronary Reserve....Pages 36-41
Identification and Management of High Risk Patients with Hypertrophic Cardiomyopathy....Pages 42-50
Hypertrophic Cardiomyopathy and Sudden Death in the Young: a Pathologist’s View....Pages 51-59
The Clinicopathologic Spectrum of Hypertrophic Cardiomyopathy. The Experience of the Italian Heart Transplant Program....Pages 60-69
Medical Treatment Options in Hypertrophic Cardiomyopathy....Pages 70-75
DDD Pacing in Hypertrophic Cardiomyopathy: State of the Art....Pages 76-80
Indications and Outcome of Cardiac Surgery for Severely Symptomatic Patients with Hypertrophic Obstructive Cardiomyopathy....Pages 81-85
Front Matter....Pages 87-87
Genetic Basis of Dilated Cardiomyopathy....Pages 89-96
Virus Infection in Cardiomyopathies: Brief Overview, Recent Advances....Pages 97-100
Organ-Specific Cardiac Autoantibodies in Dilated Cardiomyopathy: Pathogenetic Implications....Pages 101-106
Inflammatory Cardiomyopathy: Diagnostic and Therapeutical Options....Pages 107-116
Mitochondrial DNA Mutations and Cardiomyopathies....Pages 117-127
Pathophysiologic Role of Coronary Microcirculatory Impairment in Dilated Cardiomyopathy....Pages 128-137
Myocardial Catecholamines and Inotropic Response in Heart Muscle Disease....Pages 138-146
Molecular Biology of Heart Failure....Pages 147-159
Front Matter....Pages 87-87
Dilated Cardiomyopathy: Does Etiological Heterogeneity Portend Clinical Heterogeneity?....Pages 160-170
Recent Advances in Etiopathogenesis of Dilated Cardiomyopathy: Which Relevance for the Clinical Cardiologist?....Pages 171-182
The Italian Multicentric Study: Natural History of Dilated Cardiomyopathy....Pages 183-193
Mildly Dilated Cardiomyopathy....Pages 194-202
Front Matter....Pages 203-203
Immunosuppressive Treatment for Inflammatory Dilated Cardiomyopathy (Myocarditis)....Pages 205-220
Prevention of Sudden Death in Patients with Dilated Cardiomyopathy....Pages 221-228
Medical Treatment of Heart Failure: Problems in Dilated Cardiomyopathy....Pages 229-235
Treatment of Dilated Cardiomyopathies with β-adrenergic Blocking Agents....Pages 236-244
The Role of β-Blockers in the Management of Heart Failure: Results of Controlled Trials....Pages 245-253
Controversial Issues on β-Blocker Treatment: Has Metoprolol an Additive Effect to Conventional Medical Treatment in Heart Failure Due to Dilated Cardiomyopathy?....Pages 254-261
β-Blockers for Heart Failure: Practical Issues....Pages 262-273
DDD Pacing in Dilated Cardiomyopathy....Pages 274-279
End-Stage Heart Failure and Timing of Heart Transplantation....Pages 280-293
Cardiomyoplasty: Surgical Therapy for Ischemic and Idiopathic Dilated Cardiomyopathies....Pages 294-302
Left Ventricular Assist Device as Bridge to Transplantation....Pages 303-312
Back Matter....Pages 313-317